Literature DB >> 12929982

Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.

Vichit Supornsilchai1, Paravee Hiranrat, Suttipong Wacharasindhu, Sumarlee Srivuthana, Suphab Aroonparkmongkol.   

Abstract

BACKGROUND: Precocious puberty is characterized by breast development in girls prior to 8 years old and may have acne, adult odor, growth spurt and menstruation. Conventionally, gonadotropin releasing hormone (GnRH) stimulation test is a gold standard for diagnosis of central precocious puberty but it is a time-comsuming procedure that is not practical on an out patient basis.
OBJECTIVE: To evaluate the basal luteinizing hormone (LH)/follicle stimulating hormone (FSH) ratio in diagnosis of central precocious puberty in order to save time and cost. SUBJECTS AND
METHOD: The GnRH stimulation tests were performed on 51 girls with breast development before 8 years old. The 51 girls were divided into 2 groups, 24 girls with central precocious puberty (CPP) and 27 girls with premature thelarche (PT), and the clinical data and GnRH stimulation tests data were compared between the 2 groups. The authors also compared the clinical data and GnRH stimulation tests data between 13 girls with PT and 12 girls with thelarche variants (TV) who developed puberty approximately 1 year later as confirmed by GnRH stimulation test.
RESULTS: Girls with CPP had a large bone age and chronological age ratio and advancement of breast staging. Girls with TV had a greater level of basal luteinizing hormone (LH), peak LH and 120 min estradiol than girls with PT. Basal luteinizing hormone and follicle stimulating hormone (FSH) ratio greater than 0.2 can be used to diagnose CPP with 75 per cent sensitivity, 85 per cent specificity, 82 per cent positive predictive value (PPV) and 82 per cent negative predictive value (NPV).
CONCLUSION: Girls with CPP have a basal LH/FSH ratio greater than 0.2 and this can be used as a cut-off point for the diagnosis CPP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12929982

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  7 in total

1.  Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.

Authors:  Matthew D Stephen; Peter E Zage; Steven G Waguespack
Journal:  Int J Pediatr Endocrinol       Date:  2011-03-06

2.  Clinical and laboratory findings in the differential diagnosis of central precocious puberty and premature thelarche.

Authors:  Gönül Çatlı; Pınar Erdem; Ahmet Anık; Ayhan Abacı; Ece Böber
Journal:  Turk Pediatri Ars       Date:  2015-03-01

3.  Adequacy of basal luteinizing hormone levels in the diagnosis of central precocious puberty.

Authors:  Doğuş Vurallı; E Nazlı Gönç; Z Alev Özön; Ayfer Alikaşifoğlu
Journal:  Turk Pediatri Ars       Date:  2020-06-19

4.  GnRH stimulation test in precocious puberty: single sample is adequate for diagnosis and dose adjustment.

Authors:  Nurgün Kandemir; Hüseyin Demirbilek; Zeynep Alev Özön; Nazlı Gönç; Ayfer Alikaşifoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-02-23

5.  Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders.

Authors:  Hemchand K Prasad; Vaman V Khadilkar; Rahul Jahagirdar; Anuradha V Khadilkar; Sanjay K Lalwani
Journal:  Indian J Endocrinol Metab       Date:  2012-05

6.  Factors that predict a positive response on gonadotropin-releasing hormone stimulation test for diagnosing central precocious puberty in girls.

Authors:  Junghwan Suh; Myung Hyun Choi; Ah Reum Kwon; Ye Jin Kim; Jin Woo Jeong; Jung Min Ahn; Hyun Wook Chae; Duk Hee Kim; Ho-Seong Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-12-31

7.  Basal serum luteinizing hormone value as the screening biomarker in female central precocious puberty.

Authors:  Seung Heo; Young Seok Lee; Jeesuk Yu
Journal:  Ann Pediatr Endocrinol Metab       Date:  2019-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.